Pathogenetic mechanisms of severe acute respiratory syndrome

Abstract Severe acute respiratory syndrome (SARS) is an acute respiratory disease with significant morbidity and mortality. While its clinical manifestations have been extensively studied, its pathogenesis is not yet fully understood. A limited number of autopsy studies have revealed that the lungs and the immune system are the organs that sustain the most severe damage. Other organs affected include the kidneys, brain, digestive tract, heart, liver, thyroid gland and urogenital tract. The primary target cells are pneumocytes and enterocytes, both cell types abundantly expressing angiotensin-converting enzyme 2 which is the main SARS-CoV receptor. Other cell types infected include the epithelial cells of renal tubules, cerebral neurons, and immune cells. The pathology of this disease results from both direct and indirect injury. Direct injury is caused by infection of the target cells by the virus. Indirect injury mainly results from immune responses, circulatory dysfunction, and hypoxia. In this review, we summarize the major pathological findings at the gross, cellular and molecular levels and discuss the various possible mechanisms that may contribute to the pathogenesis of SARS. The implications of the proposed pathogenesis for prevention, diagnosis and therapy of the disease are discussed.

[1]  Jonathan H. Epstein,et al.  Bats Are Natural Reservoirs of SARS-Like Coronaviruses , 2005, Science.

[2]  Malik Peiris,et al.  Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.

[3]  Junya Fukuoka,et al.  Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore , 2003, Human Pathology.

[4]  M. Muller,et al.  Febrile respiratory illness in the intensive care unit setting: an infection control perspective , 2006, Current opinion in critical care.

[5]  J. Dennis,et al.  Dynamic Changes in Clinical Features and Cytokine/Chemokine Responses in Sars Patients Treated with Interferon Alfacon-1 plus Corticosteroids , 2005, Antiviral therapy.

[6]  J. Penninger,et al.  Angiotensin-converting enzyme 2 in lung diseases , 2006, Current Opinion in Pharmacology.

[7]  W. Lim,et al.  Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome , 2004, The Lancet.

[8]  L. Poon,et al.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia : a prospective study , 2003 .

[9]  G. Navis,et al.  Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis , 2004, The Journal of pathology.

[10]  Christian Drosten,et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[11]  Bor-Luen Chiang,et al.  Patient data, early SARS epidemic, Taiwan. , 2004, Emerging infectious diseases.

[12]  Mark Chappell,et al.  A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury , 2005, Nature Medicine.

[13]  Z. Lang,et al.  A clinicopathological study of three cases of severe acute respiratory syndrome (SARS) , 2003, Pathology.

[14]  Y. Guan,et al.  Detection of SARS Coronavirus in Patients with Suspected SARS , 2004, Emerging infectious diseases.

[15]  C. Hsiao,et al.  Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In Vitro , 2006, Journal of Virology.

[16]  Y. Chan,et al.  Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS) , 2003, Thorax.

[17]  F. Pei,et al.  Severe Acute Respiratory Syndrome Associated Coronavirus Is Detected in Intestinal Tissues of Fatal Cases , 2005, The American Journal of Gastroenterology.

[18]  Qingling Zhang,et al.  Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS‐CoV) in SARS patients: implications for pathogenesis and virus transmission pathways , 2004, The Journal of pathology.

[19]  F. Lai,et al.  Acute renal impairment in coronavirus-associated severe acute respiratory syndrome , 2005, Kidney International.

[20]  D. Dwyer,et al.  Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets , 2005, International Journal of Infectious Diseases.

[21]  P. Openshaw Potential therapeutic implications of new insights into respiratory syncytial virus disease , 2002, Respiratory research.

[22]  Chien-Liang Wu,et al.  Clinical and Laboratory Features of Severe Acute Respiratory Syndrome Vis-À-Vis Onset of Fever , 2004, Chest.

[23]  W. Hong,et al.  Characterization of a Unique Group-Specific Protein (U122) of the Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Virology.

[24]  J. Sung,et al.  Association of Human-Leukocyte-Antigen Class I (B*0703) and Class II (DRB1*0301) Genotypes with Susceptibility and Resistance to the Development of Severe Acute Respiratory Syndrome , 2004, The Journal of infectious diseases.

[25]  J. Sung,et al.  Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS) , 2004, Journal of Clinical Pathology.

[26]  J. Peiris,et al.  Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome , 2003, The Lancet.

[27]  Xin Li,et al.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.

[28]  P. Liao,et al.  Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity , 2005, Clinical and experimental immunology.

[29]  Larissa B. Thackray,et al.  CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Peter Cameron,et al.  A major outbreak of severe acute respiratory syndrome in Hong Kong. , 2003, The New England journal of medicine.

[31]  J. Sung,et al.  The 3a protein of severe acute respiratory syndrome-associated coronavirus induces apoptosis in Vero E6 cells. , 2005, The Journal of general virology.

[32]  M. McNutt,et al.  The spleen as a target in severe acute respiratory syndrome , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  S. Asa,et al.  Pulmonary pathology of severe acute respiratory syndrome in Toronto , 2005, Modern Pathology.

[34]  W. Hong,et al.  Overexpression of 7a, a Protein Specifically Encoded by the Severe Acute Respiratory Syndrome Coronavirus, Induces Apoptosis via a Caspase-Dependent Pathway , 2004, Journal of Virology.

[35]  Michelle M. Packard,et al.  Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan , 2005, Human Pathology.

[36]  J. A. Comer,et al.  A novel coronavirus associated with severe acute respiratory syndrome. , 2003, The New England journal of medicine.

[37]  Peter B Jahrling,et al.  Exotic emerging viral diseases: progress and challenges , 2004, Nature Medicine.

[38]  Tzei-Yi Lin,et al.  Detection of Severe Acute Respiratory Syndrome–Associated Coronavirus in Pneumocytes of the Lung , 2004, American journal of clinical pathology.

[39]  Yi Guan,et al.  Lung pathology of fatal severe acute respiratory syndrome , 2003, The Lancet.

[40]  J. Gu,et al.  Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS)1 , 2006, Biology of reproduction.

[41]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[42]  J. Sung,et al.  Clinical significance of hepatic derangement in severe acute respiratory syndrome. , 2005, World journal of gastroenterology.

[43]  Arthur S Slutsky,et al.  Angiotensin-converting enzyme 2 protects from severe acute lung failure , 2005, Nature.

[44]  K. Kain,et al.  Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by Coronavirus , 2005, The Journal of infectious diseases.

[45]  Lucy A. Perrone,et al.  Severe Acute Respiratory Syndrome and the Innate Immune Responses: Modulation of Effector Cell Function without Productive Infection1 , 2005, The Journal of Immunology.

[46]  G. Tse,et al.  Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: an in‐situ hybridization study of fatal cases , 2004, The Journal of pathology.

[47]  Yao-Hsu Yang,et al.  Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)‐associated coronavirus infection , 2005, Journal of medical virology.

[48]  K. Wong,et al.  Myopathic changes associated with severe acute respiratory syndrome: a postmortem case series. , 2005, Archives of neurology.

[49]  W. Jia,et al.  Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome. , 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.

[50]  Y. Guan,et al.  Cytokine Responses in Severe Acute Respiratory Syndrome Coronavirus-Infected Macrophages In Vitro: Possible Relevance to Pathogenesis , 2005, Journal of Virology.

[51]  Wei Cui,et al.  Expression of Lymphocytes and Lymphocyte Subsets in Patients with Severe Acute Respiratory Syndrome , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[52]  S. Diamond,et al.  Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Sung,et al.  The Spectrum of Severe Acute Respiratory SyndromeAssociated Coronavirus Infection , 2004, Annals of Internal Medicine.

[54]  Jiapei Chen,et al.  G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells , 2005, Virology Journal.

[55]  N. Zhong,et al.  Detection of Severe Acute Respiratory Syndrome Coronavirus in the Brain: Potential Role of the Chemokine Mig in Pathogenesis , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[56]  K. To,et al.  The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1—a review , 2006, Human Pathology.

[57]  J. Peiris,et al.  Mannose-Binding Lectin in Severe Acute Respiratory Syndrome Coronavirus Infection , 2005, The Journal of infectious diseases.

[58]  Y. Lau,et al.  Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells , 2005, Blood.

[59]  Min Jin,et al.  Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital , 2005, Journal of Virological Methods.

[60]  Hong Yang,et al.  Long-term SARS Coronavirus Excretion from Patient Cohort, China , 2004, Emerging infectious diseases.

[61]  John L. Sullivan,et al.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.

[62]  J. Sung,et al.  Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis , 2003, BMJ : British Medical Journal.

[63]  W. Mak,et al.  Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection , 2005, Nature Genetics.

[64]  J. Sung,et al.  Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection , 2003, Gastroenterology.

[65]  Ching-lung Lai,et al.  SARS‐associated viral hepatitis caused by a novel coronavirus: Report of three cases , 2004, Hepatology.

[66]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[67]  J. Chan,et al.  The spectrum of pathological changes in severe acute respiratory syndrome (SARS) , 2004, Histopathology.

[68]  Yu-Yong Jiang,et al.  [Difference and significance of T-lymphocyte subsets in differential diagnosis between severe acute respiratory syndrome and common atypical pneumonia]. , 2004, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.